- Home
- FDMT vs PACB Comparison
FDMT vs PACB Comparison
Compare FDMT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | PACB |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 462.8M |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | FDMT | PACB |
|---|---|---|
| Price | $8.82 | $1.35 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | ★ $31.71 | $1.67 |
| AVG Volume (30 Days) | 609.1K | ★ 6.0M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $85,209,000.00 | ★ $93,468,000.00 |
| Revenue This Year | N/A | $11.32 |
| Revenue Next Year | $70.28 | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | 3.04 |
| 52 Week Low | $3.68 | $1.09 |
| 52 Week High | $12.34 | $2.73 |
Technical Indicators
Market Signals| Indicator | FDMT | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 44.80 | 44.77 |
| Support Level | $8.39 | $1.18 |
| Resistance Level | $8.80 | $1.40 |
| Average True Range (ATR) | 0.65 | 0.13 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 15.87 | 26.72 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.